The largest database of trusted experimental protocols

S aureus

Manufactured by Thermo Fisher Scientific
Sourced in United Kingdom, United States

S. aureus is a bacterial strain commonly used in laboratory settings. It is a Gram-positive, spherical-shaped bacteria that is known for its ability to cause a variety of infections in humans. The strain is often used in research and testing to evaluate the effectiveness of antimicrobial agents and other medical interventions.

Automatically generated - may contain errors

14 protocols using s aureus

1

Intracellular Routing of Staphylococcus aureus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Indirect immunofluorescence (IFC) was done using standard protocol. A list of antibodies, dilutions, source and catalogue number are provided in Table S2. Images were acquired on an inverted fluorescent microscope and analysed using NIS elements software (Nikon TS100; Melville, NY). To evaluate bacterial infectivity and intracellular S. aureus routing, cells were incubated in serum‐free EpiLife media without calcium and magnesium (Thermo/Fisher) for 2 h. Then, inactivated, fluorescently‐labelled S. aureus (Invitrogen) was added to cultures (1 × 106 particles/ml) for 4 h or overnight. After extensive washes, cells were fixed in 4% PFA and subjected for IFC detection of the intracellular structures using protein‐specific antibodies. Slides were imaged on confocal Zeiss LSM780 NLO confocal microscope and analysed using Zeiss LSM imaging software (White Plains, NY).
+ Open protocol
+ Expand
2

Isolates From American Type Culture Collection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolates used in this study were obtained from the American Type Culture Collection (ATCC): H. influenzae (ATCC 49766), S. aureus, (ATCC 29213), S. pneumoniae (ATCC 49619) and P. aeruginosa (ATCC 27853). All isolates were stored at -80 °C prior to inoculation onto chocolate blood agar (H. influenzae: Oxoid, Basingstoke, UK) or blood agar (S. aureus, S. pneumoniae, P. aeruginosa: Oxoid, Basingstoke, UK) and incubated at 37 °C in 5% CO2 (H. influenzae, S. pneumoniae), or in air (S. aureus, P. aeruginosa).
+ Open protocol
+ Expand
3

Immunoprecipitation of S. aureus-Infected Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were pre-incubated with DMEM for 1 h at 37°C in 6-well plates. After pre-incubation, 100 µg/mL S. aureus (Invitrogen) was added to tissue culture cells, followed by incubation for the indicated time. The cells were then washed with PBS and lysed with lysis buffer (25 mM HEPES, pH 7.4, 100 mM NaCl, 5 mM MgCl2, 0.1% NP-40, 2% glycerol, and 1 mM DTT) containing protease inhibitors. The lysates were subjected to immunoprecipitation or the GST-R5BD pull-down assay as described earlier.
+ Open protocol
+ Expand
4

Phagocytosis Assay for E. coli and S. aureus

Check if the same lab product or an alternative is used in the 5 most similar protocols
SL2 cells were soaked with 1.25 μg of dsRNAs in 96 well plate for 3 days prior to phagocytosis assays. Fluorescein-labeled E. coli (K-12 strain), and Staphylococcus aureus (Wood strain, without protein A) (Invitrogen), were washed 3 times with PBS by centrifugation and sonicated for 3 times at 50 kHz for 20 s. Twenty micrograms of bacterial particles were added to each well at 4°C, the plates were centrifuged 300xg for 3 min at 4°C, and incubated in a 27°C water bath for 20 or 40 min (for E. coli and S. aureus, respectively). Cells and bacteria were removed from plates at 4°C by pipetting 300 μL of a 0.1% Trypan Blue solution in PBS pH 5.4 to quench the fluorescein from extracellular bacteria. The mount of bacteria inside live cells was quantified by flow cytometry (Ramet et al., 2002 (link)).
+ Open protocol
+ Expand
5

THP-1 Phagocytosis Assay with Inhibitor

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP-1 cells were either treated with 10 µM cytochalasin D (PHZ1063, Gibco) at 37 °C and 5% CO2 for 30 min or left untreated. S. aureus, E. coli, zymosan A, dextran (25 µg/mL, 10 kDa, P10361) or transferrin particles conjugated with pHrodo red were purchased from Thermo Fisher Scientific. Particles were added to cells and cells were incubated at 37 °C and 5% CO2 for 1 h. Of note, cytochalasin D was not removed before addition of particles and the final concentration during particle uptake was 7.5 µM. After the incubation, cells were placed on ice to stop further phagocytosis. Cells were stained with anti-Thy1.1-APC (clone: HIS51, eBioScience) and DAPI (Thermo Fisher Scientific), and analyzed on BD LSRFortessa X20 (BD Biosciences). Cells were gated based on FSC/SSC, singlets, live (DAPI-) and Thy1.1+ cells using FlowJo V10.5.3 or FACS DIVA (Becton, Dickinson & Company). The mean fluorescence intensity (MFI) was determined and normalized to the MFI of non-transduced cells.
+ Open protocol
+ Expand
6

Investigating MEK1/2 Inhibition in Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MEK1/2 inhibitor compounds PD0325901 (catalog # S1036), CI-1040 (catalog # S1020), and trametinib (catalog # S2673) were purchased from Selleck for use in in vitro cell culture experiments. PD0325901 and trametinib were used at 0.5 μM and CI-1040 was used at 10 μM. PD0325901 (catalog # PZ0162) used for in vivo experiments was from Sigma. Recombinant human M-CSF (catalog # 300-25) and murine M-CSF (catalog # 315-02) were from Peprotech. Ficoll Paque Plus (catalog # 17-1440-03) was from Cytiva. Human AB serum was from Sigma (catalog # H6914). LPS from Pseudomonas aeruginosa was from Sigma (catalog # L8643). Pam3CSK4 (catalog # tlrl-pms) and FSL1 (catalog # tlrl-fsl) were from InvivoGen (San Diego, CA). The pHrodo Red E. coli (catalog # P35361), S. aureus (catalog # A10010), and zymosan (catalog # P35364) bioparticles were from ThermoFisher Scientific. Antibodies used in these studies are listed in Supplementary Table 1.
+ Open protocol
+ Expand
7

Opsonization of S. aureus by IVIg

Check if the same lab product or an alternative is used in the 5 most similar protocols
An S. aureus (Thermo Fisher Scientific, Waltham, MA, USA) vial was resuspended in 5 mL PBS. The vial was vortexed 3 × 15 s at the highest setting. The bioparticle solution was combined with IVIg, S2-IVIg or ds-IVIg in a 1:1 ratio. The mixture was allowed to rotate for 1 h at 37 °C. Subsequently, each tube was centrifuged at 1500× g for 10 min at 4 °C; the supernatants were removed and the pellet was resuspended in 1 mL PBS. The centrifugation and washing steps were repeated for a total of two washes with PBS. Finally, the washed pellet was resuspended in 200 µL of assay media.
+ Open protocol
+ Expand
8

Antibody Screening and Conjugation for Bacterial Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercial rabbit polyclonal antibodies against key Gram-positive (S. aureus.) and Gram-negative (E. coli, K. pneumoniae, and P. aeruginosa) bacteria were selected by cross-reactivity screening using ELISA and fluorescence-activated cell sorting (FACS) analysis of >107 intact bacteria/mL (Supporting Information 2). Screening identified polyclonal antibodies recognizing S. aureus (Thermo Fisher Scientific), E. coli (MyBioSource, San Diego, CA), K. pneumoniae (Thermo Fisher Scientific), and P. aeruginosa (Abcam, Cambridge, U.K.). These were separately conjugated to ALP (Thermo Fisher Scientific) using the FastLink ALP kit (Abnova, Taipei City, Taiwan), to biotin-PEG4 and to Dylight 488 using the EZ-Link NHS-conjugation kits (Thermo Fisher Scientific). Antibody conjugates were stored at 4 °C.
+ Open protocol
+ Expand
9

Drosophila Infection Bioassay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Procedures were performed as described previously (Shokal and Eleftherianos, 2017b (link)). Bacteria M. luteus (#4698), S. aureus (#12600) and L. monocytogenes (#19115) were purchased from ATCC (USA). Bacteria P. asymbiotica, P. luminescens and M. luteus were cultured in sterile Luria-Bertani (LB) broth for 18–22 h at 30°C on a shaker at 225 rpm. E. coli, M. luteus, S. aureus and L. monocytogenes were cultured at 37°C on a shaker at 225 rpm. For infections, bacterial concentrations were adjusted to an optical density (OD, 600 nm) of 0.1 for P. luminescens, 0.25 for P. asymbiotica, M. luteus, S. aureus and L. monocytogenes, and 0.015 for E. coli, as measured by spectrophotometer (NanoDropTM 2000c, Thermo Fisher Scientific). Adult flies of seven- to ten-day-old (40 / condition) were anesthetized with CO2 and injected in the thorax with 20 nL of bacterial suspension or sterile 1X PBS (injury control). Flies were kept at 25°C, and survival was monitored for 96 h after injection.
+ Open protocol
+ Expand
10

Inactivated E. coli and S. aureus Induce Nitric Oxide

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MDM from each sample were seeded in 3 wells of a 48-well plate at a density of 2 × 10 5 cells per well in AIM V Medium containing 5 ng/mL of GM-CSF and incubated overnight. One well was assigned as the control and the other 2 wells were assigned as treatment groups and were exposed to inactivated E. coli (MOI 5, determined by titration (MOI 1, 5, 10, and 50) to induce maximum NO -using minimum MOI, the strain was isolated from a mastitic cow by a microbiologist, P. Boerlin, Ontario Veterinary College) or S. aureus (MOI 10, determined by titration (MOI 1, 5, 10, and 50) to induce maximum NO -using minimum MOI; Thermo Fisher Scientific Inc.) for 48 h. Supernatant from each well was collected and the concentration of nitric oxide (NO -) was measured with the Measure-iT High-Sensitivity Nitrite Assay Kit (Thermo Fisher Scientific Inc.). The concentration of NO -for every sample in the challenge groups was subtracted by its replicate in the control group.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!